Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | QPCT | Q16769 | 1/20 | 0.33 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.33 |
| ▸ | PLG | P00747 | 3/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31320110 | 0.99 | EPHX2 (0.34) | EPHX2QPCTQPCTLPLGMAP4K4 | |
| SCHEMBL31320088 | 0.82 | PLG (0.41) | EPHX2QPCTQPCTLPLGMAP4K4 | |
| SCHEMBL31320057 | 0.82 | PLG (0.41) | EPHX2QPCTQPCTLPLGMAP4K4 | |
| Hydrochloric Acid SCHEMBL31320089 | 0.78 | PARP1 (0.34) | EPHX2 | |
| SCHEMBL31320095 | 0.78 | EPHX2 (0.35) | EPHX2QPCTQPCTLMAP4K4 | |
| SCHEMBL31320079 | 0.78 | EPHX2 (0.35) | EPHX2QPCTQPCTLMAP4K4 | |
| SCHEMBL239491 | 0.75 | MEN1 (0.46) | EPHX2QPCTQPCTLPLGMAP4K4 | |
| Hydrochloric Acid SCHEMBL27035787 | 0.73 | MEN1 (0.49) | EPHX2QPCTQPCTLPLGMAP4K4 | |
| SCHEMBL20691034 | 0.72 | MEN1 (0.37) | EPHX2QPCTQPCTLPLGMAP4K4 | |
| SCHEMBL12596284 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066329-A1 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-02-27 | — | — | US | disclosed |
| WO-2025036713-A1 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066329-A1 | PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN | QPCT, QPCTL, GLUL | EPHX2 4746/4885QPCT 1/4885QPCTL 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.